Following treatment with IL-23 plus P/I, the abundance of TH-17 cells in RA SF was significantly (p < 0.05) greater than observed with normal PB and RA PB treated in the same fashion (Figures 1b, 1f and 2). Here, IL23A is linked to rheumatoid arthritis.